Consumer products giant Clorox (NYSE:CLX) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $1.67 billion. Its non-GAAP profit of $1.39 per share was 3% below analysts’ consensus estimates.
Consumer products giant Clorox (NYSE:CLX) reported Q4 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $1.67 billion. Its non-GAAP profit of $1.39 per share was 3% below analysts’ consensus estimates.
Wall Street’s bearish price targets for the stocks in this article signal serious concerns.
Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
In a move that fundamentally reshapes the global hygiene landscape, The Clorox Company (NYSE: CLX) announced on January 22, 2026, that it has entered into a definitive agreement to acquire GOJO Industries, the privately held manufacturer of the iconic Purell hand sanitizer brand. The $2.25 billion all-cash transaction represents
The opening weeks of 2026 have ushered in a transformative wave of merger and acquisition (M&A) activity in the United States, signaling a definitive end to the deal-making drought that plagued the early 2020s. Following a robust 2025 that saw total deal values climb to a staggering $2.3
The story of e.l.f. Beauty (NYSE: ELF) is one of the most compelling narratives in the modern consumer discretionary sector. Once a niche brand known for selling $1 cosmetics in the corners of retail stores, e.l.f. has evolved into a disruptive powerhouse that is redefining the global beauty landscape. As of January 16, 2026, the [...]
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
As of January 9, 2026, the global beauty industry is undergoing a profound structural shift, and no company embodies this transformation more than e.l.f. Beauty, Inc. (NYSE: ELF). For the past decade, e.l.f.—which stands for Eyes, Lips, Face—has evolved from a budget-friendly niche player into a disruptive powerhouse that challenges the hegemony of legacy giants [...]
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
Over the last six months, Clorox’s shares have sunk to $100.95, producing a disappointing 18.9% loss - a stark contrast to the S&P 500’s 9.9% gain. This might have investors contemplating their next move.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how household products stocks fared in Q3, starting with Central Garden & Pet (NASDAQ:CENT).
